Position in BMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,765,149
+$3,114,331 QoQ
Shares Held
169,475
+54.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#396
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $147,518,356 across 14 Drug Manufacturers - General names. BMY ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,420 | $26,891,222 | |
| 2 | JNJ |
Johnson & Johnson
|
101,232 | $25,709,891 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
135,292 | $17,092,791 | |
| 4 | NVS |
Novartis AG
|
105,819 | $16,583,953 | |
| 5 | ABBV |
AbbVie Inc.
|
49,487 | $12,452,908 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
169,475 | $9,765,149 | |
| 7 | BIIB |
Biogen Inc.
|
34,283 | $7,407,184 | |
| 8 | AZN |
Astrazeneca PLC
|
34,429 | $6,528,426 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,765,149 | 169,475 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,650,818 | 109,659 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,375,403 | 62,577 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $898,346 | 19,919 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,059,855 | 22,896 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,250,774 | 36,904 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,227,841 | 39,389 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,233,636 | 23,843 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $547,116 | 13,174 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $929,664 | 17,143 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $803,771 | 15,665 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $867,407 | 14,945 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,346,467 | 21,055 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,673,004 | 24,138 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $3,046,291 | 42,339 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $3,555,566 | 50,015 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,488,409 | 32,317 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,673,117 | 22,910 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $839,792 | 13,469 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $655,603 | 11,080 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $945,770 | 14,154 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $701,121 | 11,106 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $735,737 | 11,861 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $609,773 | 10,114 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $535,315 | 9,104 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $410,803 | 7,370 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||